Zobrazeno 1 - 10
of 30
pro vyhledávání: '"David F. Claxton"'
Autor:
Christopher J. Pizzola, Joseph Cioccio, Kevin L. Rakszawski, Myles Nickolich, W. Christopher Ehmann, Witold B. Rybka, Baldeep Wirk, Seema Naik, Hong Zheng, Brooke Silar, Hiroko Shike, Shouhao Zhou, Shin Mineishi, Kentaro Minagawa, David F. Claxton
Publikováno v:
Bone Marrow Transplantation. 57:1743-1745
Autor:
Shin Mineishi, Pan Zheng, Robert F. Paulson, W. Christopher Ehmann, Hiroko Shike, Bei Jia, K. Sandeep Prabhu, Todd D. Schell, Yi Zhang, Chenchen Zhao, Michael G. Bayerl, Hong Zheng, David F. Claxton, Leonard D. Shultz
Publikováno v:
J Leukoc Biol
The prognosis for acute myeloid leukemia (AML) relapse post allogeneic hematopoietic stem cell transplantation (alloSCT) is dismal. Novel effective treatment is urgently needed. Clinical benefit of alloSCT greatly relies on the graft-versus-leukemia
Autor:
Chenchen Zhao, Matthew Bartock, Bei Jia, Neal Shah, David F. Claxton, Baldeep Wirk, Kevin L. Rakszawski, Myles S. Nickolich, Seema G. Naik, Witold B. Rybka, W Christopher C. Ehmann, Raymond J. Hohl, Jessica Valentin, Michelle Bernas-Peterson, Emily M. Gerber, Michele Zimmerman, Joseph A. Mierski, Shin Mineishi, Hong Zheng
Publikováno v:
Journal of Hematology & Oncology. 15
Despite the increased usage of post-transplant cyclophosphamide (PTCy) in allogeneic hematopoietic stem cell transplantation (allo-HSCT), our knowledge of immune reconstitution post-allo-HSCT in the setting of PTCy is limited. Adequate immune reconst
Autor:
R.L. Bayer, Jerald P. Radich, Maria Brown, M. Lynn Savoie, Bruno C. Medeiros, Harry P. Erba, John M. Pagel, Selina M. Luger, Stephen A. Strickland, Sanjay R. Mohan, Guillermo Garcia-Manero, Dennis L. Confer, David A. Rizzieri, Stephen R. Spellman, Richard Stone, Geoffrey L. Uy, David F. Claxton, Mark R. Litzow, Min Fang, Frederick R. Appelbaum, Megan Othus, Mikkael A. Sekeres, Jeffrey Chell, Bayard L. Powell, James Essell, Guido Marcucci, Anna Moseley, Richard A. Larson, Tara L. Lin
Publikováno v:
JCO Oncol Pract
PURPOSE: Patients with acute myeloid leukemia with high-risk cytogenetics in first complete remission (CR1) achieve better outcomes if they undergo allogeneic hematopoietic cell transplantation (HCT) compared with consolidation chemotherapy alone. Ho
Autor:
Witold B. Rybka, Kristina Gvozdjan, Shin Mineishi, Hiroko Shike, Jozef Malysz, Carolyn Fisher, Heather Casey, Zheng Hong, Mike G Bayerl, Lorie H. Kumer, Maria Baker, Carrie L. Mowery, Jennifer Tyler, Christopher Ehmann, David F. Claxton, Seema Naik
Publikováno v:
Laboratory medicine. 51(6)
Chimerism testing by short tandem repeats (STRs) is used to monitor engraftment after allogeneic hematopoietic stem cell transplantation (HSCT). Generally, STR alleles are stable and transferred from parent to child or from donor to recipient. Howeve
Autor:
Kosuke Miki, Kevin Rakszawski, Shin Mineishi, Seema Naik, Henry N. Wagner, David F. Claxton, Hiroko Shike
Publikováno v:
International Journal of Hematology. 108:348-350
Approximately 30-40% of patients with acute myeloid leukemia (AML) experience induction failures. In these patients who do not achieve remission with two cycles of standard induction therapies, the probability of achieving remission with subsequent i
Autor:
David F. Claxton, Junjia Zhu, Jeffrey J. Pu, Michael G. Bayerl, Joyson Poulose, Jozef Malysz, Julie Fanburg-Smith
Publikováno v:
Br J Haematol
Autor:
Shin Mineishi, Gina Mackey, W. Christopher Ehmann, Christopher J Pizzola, Witold B. Rybka, Brook Silar, Kevin Rakszawski, Kentaro Minagawa, Hong Zheng, Baldeep Wirk, Seema Naik, David F. Claxton
Publikováno v:
Blood. 134:5724-5724
Introduction: Non-myeloablative conditioning regimens enable elderly and younger patients with significant comorbidities to undergo allogenic stem cell transplant (allo SCT). These regimens allow for the benefit of graft-versus-leukemia (GVL) effect
Autor:
Lorie H. Kumer, Carolyn Fisher, Hiroko Shike, David F. Claxton, Heather Casey, Robert J. Greiner, Shin Mineishi, Seema Naik, Rybka Witold, Baldeep Wirk, Jennifer Tyler, Christopher Ehmann, Hong Zheng, Brown Valerie
Publikováno v:
Human Immunology. 80:41
Autor:
D W Dougherty, David F. Claxton, Witold B. Rybka, Jeffrey Sivik, Christopher Ehmann, Joseph J. Drabick, Giampaolo Talamo
Publikováno v:
Bone Marrow Transplantation. 44:157-161
High-dose melphalan is considered the current standard of care among the preparative regimens used in peripheral blood autologous SCT (ASCT) for multiple myeloma (MM). We report the results of a single ASCT in 79 MM patients using the BU/CY condition